Publications

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

 97
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Next Article

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

Oral polyphenol-based microbeads with synergistic demulsification and fat locking for obesity treatment

Oral polyphenol-based microbeads with synergistic demul...

 92

Dnmt1 determines bone length by regulating energy metabolism of growth plate chondrocytes

Dnmt1 determines bone length by regulating energy metab...

 42

Conceptual and methodological flaws undermine claims of a link between the gut microbiome and autism

Conceptual and methodological flaws undermine claims of...

 49